Overview

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

Status:
Completed
Trial end date:
2010-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of etelcalcetide in healthy young males.
Phase:
Phase 1
Details
Lead Sponsor:
KAI Pharmaceuticals
Collaborator:
Nucleus Network Ltd